ProQR Therapeutics (PRQR) Free Cash Flow (2013 - 2022)
ProQR Therapeutics recorded quarterly Free Cash Flow of -$15.8 million in Q4 2022, down 3.84% quarter-over-quarter from -$15.2 million in Q3 2022, and down 445.04% year-over-year from $4.6 million in Q4 2021.
ProQR Therapeutics' Free Cash Flow history runs 10 years deep, the most recent figure standing at -$15.8 million for Q4 2022.
- In Q4 2022, Free Cash Flow fell 445.04% year-over-year to -$15.8 million; the TTM figure through Dec 2025 stood at $0.0 (changed 0.0% YoY), while the FY2025 annual figure was -$62.6 million, down 55.03% from the prior year.
- Free Cash Flow came in at -$15.8 million for Q4 2022 at ProQR Therapeutics, down from -$15.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $4.6 million in Q4 2021 to a low of -$22.7 million in Q1 2022.
- A 5-year average of -$9.8 million and a median of -$11.6 million in 2021 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow sank 196720898.6% in 2019 and surged 133.06% in 2021, its largest moves.
- ProQR Therapeutics' Free Cash Flow stood at -$10359.3 in 2018, then tumbled by 125095.58% to -$13.0 million in 2019, then slipped by 6.99% to -$13.9 million in 2020, then surged by 133.06% to $4.6 million in 2021, then tumbled by 445.04% to -$15.8 million in 2022.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$15.8 million, -$15.2 million, and -$15.6 million for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -15.83 Mn |
| Dec 31, 2022 | -15.83 Mn |
| Sep 30, 2022 | -15.24 Mn |
| Sep 30, 2022 | -15.24 Mn |
| Jun 30, 2022 | -15.59 Mn |
| Jun 30, 2022 | -15.59 Mn |
| Mar 31, 2022 | -22.70 Mn |
| Mar 31, 2022 | -22.70 Mn |
| Dec 31, 2021 | 4.59 Mn |
| Dec 31, 2021 | 4.59 Mn |
| Sep 30, 2021 | -9.30 Mn |
| Sep 30, 2021 | -9.30 Mn |
| Jun 30, 2021 | -11.95 Mn |
| Jun 30, 2021 | -11.95 Mn |
| Mar 31, 2021 | -14.15 Mn |
| Mar 31, 2021 | -14.15 Mn |
| Dec 31, 2020 | -13.88 Mn |
| Dec 31, 2020 | -13.88 Mn |
| Sep 30, 2020 | -11.15 Mn |
| Sep 30, 2020 | -11.15 Mn |
| Jun 30, 2020 | -11.17 Mn |
| Jun 30, 2020 | -11.17 Mn |
| Mar 31, 2020 | -16,348.23 |
| Mar 31, 2020 | -16,348.23 |
| Dec 31, 2019 | -12.97 Mn |
| Dec 31, 2019 | -12.97 Mn |
| Sep 30, 2019 | -9.73 Mn |
| Sep 30, 2019 | -9.73 Mn |
| Jun 30, 2019 | -12.13 Mn |
| Jun 30, 2019 | -12.13 Mn |
| Mar 31, 2019 | -13.80 Mn |
| Mar 31, 2019 | -13.80 Mn |
| Dec 31, 2018 | -10,359.31 |
| Dec 31, 2018 | -10,359.31 |
| Sep 30, 2018 | -4.84 Mn |
| Sep 30, 2018 | -4.84 Mn |
| Jun 30, 2018 | -6.26 Mn |
| Jun 30, 2018 | -6.26 Mn |
| Mar 31, 2018 | 7.01 |
| Mar 31, 2018 | 7.01 |
| Dec 31, 2017 | 10,249.55 |
| Dec 31, 2017 | 10,249.55 |
| Sep 30, 2017 | -12.21 |
| Sep 30, 2017 | -12.21 |
| Jun 30, 2017 | -10.77 Mn |
| Jun 30, 2017 | -10.77 Mn |
| Mar 31, 2017 | 9,309.53 |
| Mar 31, 2017 | 9,309.53 |
| Dec 31, 2016 | -39.66 Mn |
| Dec 31, 2016 | -39.66 Mn |
| Sep 30, 2016 | -11,575.95 |
| Sep 30, 2016 | -11,575.95 |
| Dec 31, 2015 | -27.96 Mn |
| Dec 31, 2015 | -27.96 Mn |
| Sep 30, 2015 | -6,905.06 |
| Sep 30, 2015 | -6,905.06 |
| Mar 31, 2015 | -5.41 Mn |
| Mar 31, 2015 | -5.41 Mn |
| Dec 31, 2014 | -5.58 Mn |
| Dec 31, 2014 | -5.58 Mn |
| Sep 30, 2014 | -5.25 Mn |
| Sep 30, 2014 | -5.25 Mn |
| Mar 31, 2014 | -2.44 Mn |
| Mar 31, 2014 | -2.44 Mn |
| Dec 31, 2013 | -1.43 Mn |
| Dec 31, 2013 | -1.43 Mn |
| Sep 30, 2013 | -800,323.31 |
| Sep 30, 2013 | -800,323.31 |